William Blair & Company
IDIX

William Blair & Company’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

William Blair & Company’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-14,300
Closed -$51K – 2114
2013
Q2 		$51K Buy
+14,300
New +$58.5K ﹤0.01% 1920

Other funds holding IDIX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company's IDIX Position: Q3 2013 in Review

William Blair & Company sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2013, closing a stake of 14,300 shares — an estimated $51K sold.

William Blair & Company first reported a position in IDIX in Q2 2013 and held it in 1 quarter. The position peaked at $51K in Q2 2013. 93 funds tracked by Wall St. Rank hold IDIX as of Q3 2013.

  • William Blair & Company reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • William Blair & Company sold 14,300 IDENIX PHARMACEUTICALS INC shares in Q3 2013, an estimated $51K.
  • William Blair & Company first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • William Blair & Company's IDENIX PHARMACEUTICALS INC position peaked at $51K in Q2 2013.
  • 93 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2013.

Based on William Blair & Company's 13F filing for Q3 2013, filed 12 Nov 2013.